Evidence map›Paper›PMID 38005218›Full record

ArticleMolecules (Basel, Switzerland)2023

Lateral Flow Immunoassay Based on Quantum-Dot Nanobeads for Detection of Chloramphenicol in Aquatic Products.

Qian Han, Ling Fan, Xiuying Liu, Yiwei Tang, Pingping Wang, Zaixi Shu, Wei Zhang, Lijie Zhu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qian HanSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.
Ling FanCollege of Food Science and Technology, Bohai University, Jinzhou 121013, China.
Xiuying LiuSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.ORCID 0000-0002-7688-9112
Yiwei TangCollege of Food Science and Technology, Hebei Agricultural University, Baoding 071001, China.
Pingping WangSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.
Zaixi ShuSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.
Wei ZhangSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.ORCID 0000-0001-6777-6848
Lijie ZhuSchool of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430028, China.

Funding

National Key R&D Program of China 2019YFD0901701Scientific Research Foundation of Wuhan Polytechnic University 2023
6 · The paper itself

Abstract

Quantum dot nanobeads (QBs) were used as signal source to develop competitive lateral flow immunoassay (LFIA) for the detection of chloramphenicol (CAP). The quantitative detection of CAP was achieved by calculating the total color difference (∆E) values of the test line (T line) using the images of test strips. QB-based LFIA (QBs-LFIA) allowed the effective dynamic linear detection of CAP in the range of 0.1-1.5 ng/mL. The limit of detection (LOD) was 3.0 ng/mL, which was 50 and 667 times lower than those achieved for two different brands of colloidal gold kits. The recoveries of CAP during real-sample detection were 82.82-104.91% at spiked levels of 0.1, 0.7, and 1.5 ng/mL. These results indicate that the developed QBs-LFIA facilitates the sensitive detection of CAP.

Indexed as

ChloramphenicolQuantum DotsGold ColloidImmunoassayLimit of DetectionChloramphenicolGold Colloidchloramphenicolfluorescent test striplateral flow immunoassayquantum dot nanobeads

Identifiers

PMID38005218
PMCPMC10673565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.